Padres Pedal the Cause Is Now Curebound Cancer Challenge, Kicks Off with 1.1 Million Philanthropic Gift as Organization Doubles Down on Mission to End Cancer
PHPIX Fund | USD 27.85 0.48 1.75% |
Slightly above 57% of Pharmaceuticals Ultrasector's investor base is looking to short. The analysis of overall sentiment of trading Pharmaceuticals Ultrasector Profund mutual fund suggests that many investors are alarmed at this time. Pharmaceuticals Ultrasector's investing sentiment can be driven by a variety of factors including economic data, Pharmaceuticals Ultrasector's earnings reports, geopolitical events, and overall market trends.
Pharmaceuticals |
Curebound launched its new Curebound Cancer Challenge today. An evolution of Curebounds renowned Padres Pedal the Cause event, Curebound Cancer Chall
Read at businesswire.com
Pharmaceuticals Ultrasector Fundamental Analysis
We analyze Pharmaceuticals Ultrasector's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharmaceuticals Ultrasector using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharmaceuticals Ultrasector based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Pharmaceuticals Ultrasector is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Pharmaceuticals Ultrasector Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharmaceuticals Ultrasector mutual fund to make a market-neutral strategy. Peer analysis of Pharmaceuticals Ultrasector could also be used in its relative valuation, which is a method of valuing Pharmaceuticals Ultrasector by comparing valuation metrics with similar companies.
Peers
Pharmaceuticals Ultrasector Related Equities
FRGOX | Franklin Gold | 1.37 | ||||
IOGYX | Invesco Gold | 1.07 | ||||
SGDLX | Sprott Gold | 0.78 | ||||
FGDIX | Fidelity Advisor | 0.48 | ||||
VGSBX | Vy Goldman | 0.43 | ||||
MXKJX | Great-west Goldman | 0.1 | ||||
GEBRX | Goldman Sachs | 0.30 |
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |